 SOUTH SAN FRANCISCO, Calif., April 07, 2022 GLOBE NEWSWIRE -- Harpoon Therapeutics, Inc. NASDAQ: HARP, a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate in a fireside chat at the Canaccord Genuity Horizons in Oncology Virtual Conference. The discussion will take place on Thursday, April 14, 2022 at 2:30 p.m. ET 11:30 a.m. PT. 